Korro Bio (KRRO) Short-term Investments (2019 - 2026)

Korro Bio's Short-term Investments history runs 8 years deep, the most recent figure standing at $52.3 million for Q1 2026.

• Quarterly Short-term Investments rose 2.88% year-over-year to $52.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.3 million (up 2.88% YoY) and the FY2025 annual result came in at $53.3 million, down 24.3% from the prior year.
• Short-term Investments was $52.3 million for Q1 2026 at Korro Bio, down from $53.3 million in the prior quarter.
• Across five years, Short-term Investments topped out at $73.8 million in Q3 2024 and bottomed at $600000.0 in Q4 2022.
• A 5-year average of $45.6 million and a median of $54.4 million in 2022 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments sank 98.83% — and 2024, when it jumped 1857.0%.
• Korro Bio's Short-term Investments stood at $600000.0 in 2022, then surged by 500.0% to $3.6 million in 2023, then soared by 1857.0% to $70.5 million in 2024, then retreated by 24.3% to $53.3 million in 2025, then fell by 1.99% to $52.3 million in 2026.
• Business Quant data shows KRRO's Short-term Investments at $52.3 million in Q1 2026, $53.3 million in Q4 2025, and $68.3 million in Q3 2025.